Peter Lichter
Lichter, Peter 1957-
VIAF ID: 12146095357400372637 (Personal)
Permalink: http://viaf.org/viaf/12146095357400372637
Preferred Forms
-
100 1 _
‡a
Lichter, Peter
‡d
1957-
-
100 0 _
‡a
Peter Lichter
4xx's: Alternate Name Forms (8)
5xx's: Related Names (5)
- 510 2 _
‡a
Deutsche Akademie der Naturforscher Leopoldina
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 551 _ _
‡a
Heidelberg
‡4
ortw
‡4
https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _
‡a
Klinikum Heidelberg
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 551 _ _
‡a
Mannheim
‡4
ortg
‡4
https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _
‡a
Universität Heidelberg
‡b
Medizinische Fakultät
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
Works
| Title | Sources |
|---|---|
| BCAT1 redox function maintains mitotic fidelity |
|
| Clonal Evolution Dynamics and Tumor Microenvironment Composition of Chronic Lymphocytic Leukemia |
|
| Dissecting the genomic complexity underlying medulloblastoma |
|
| Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia |
|
| DNA fragility in murine neural progenitor cells attempts to identify early replicating fragile sites and interrupt transcription activity |
|
| Elastic SCAD as a novel penalization method for SVM classification tasks in high-dimensional data |
|
| EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia |
|
| Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the in cis downregulation of a gene cluster that targets NF-kB |
|
| Evidence for multi-copy Mega-NUMTs in the human genome |
|
| Evolutionary trajectories of IDHWT glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis |
|
| FACT – a framework for the functional interpretation of high-throughput experiments |
|
| landscape of genomic alterations across childhood cancers |
|
| Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks |
|
| Macromolecular crowding and its potential impact on nuclear function |
|
| Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks |
|
| Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions. |
|
| Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress |
|
| Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. |
|
| Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations |
|
| Medulloblastomics: the end of the beginning |
|
| Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma |
|
| Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status |
|
| Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. |
|
| MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. |
|
| MicroRNA profiling of primary high-grade soft tissue sarcomas |
|
| miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells |
|
| Molecular characterization of AML with ins(21;8)(q22;q22q22) reveals similarity to t(8;21) AML. |
|
| Molecular characterization of medulloblastomas with extensive nodularity (MBEN). |
|
| Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis |
|
| Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups |
|
| Molecular classification of human gliomas using matrix-based comparative genomic hybridization |
|
| Molecular signatures classify astrocytic gliomas by IDH1 mutation status. |
|
| Molecular staging of intracranial ependymoma in children and adults |
|
| Molecular subgroups of medulloblastoma: the current consensus |
|
| Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas |
|
| Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer |
|
| MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema |
|
| Neoadjuvant therapy with gemcitabine in breast cancer |
|
| New brain tumor entities emerge from molecular classification of CNS-PNETs |
|
| Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study |
|
| NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib |
|
| No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients |
|
| Nos2 inactivation promotes the development of medulloblastoma in Ptch1(+/-) mice by deregulation of Gap43-dependent granule cell precursor migration |
|
| Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes. |
|
| Novel mode of action of the branched-chain amino acid transaminase BCAT1 in glioblastoma |
|
| Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome |
|
| Nuclear body movement is determined by chromatin accessibility and dynamics |
|
| The nuclear receptor tailless is required for neurogenesis in the adult subventricular zone |
|
| Nuclear RNAs confined to a reticular compartment between chromosome territories |
|
| Obligation for cell line authentication: appeal for concerted action |
|
| Off-target effects of siRNA specific for GFP |
|
| Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma |
|
| Optimization of high-density cDNA-microarray protocols by 'design of experiments'. |
|
| Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci |
|
| Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth |
|
| P42: High resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histological and genetic subgroups of invasive breast cancer |
|
| P45: Comprehensive genomic analysis of desmoplastic medulloblastomas reveals novel amplified genes and supports a monoclonal origin of the different histologic components |
|
| Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge |
|
| Patient-based cross-platform comparison of oligonucleotide microarray expression profiles. |
|
| PCM-15SOMATIC CRISPR/Cas9-MEDIATED TUMOR SUPPRESSOR DISRUPTION ENABLES VERSATILE BRAIN TUMOR MODELING. |
|
| PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia |
|
| penalizedSVM: a R-package for feature selection SVM classification |
|
| Podoplanin is a novel fos target gene in skin carcinogenesis |
|
| Preeclampsia: increased expression of soluble ADAM 12. |
|
| Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells |
|
| Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort |
|
| Protein phosphatase 1, regulatory subunit 15B is a survival factor for ERα-positive breast cancer |
|
| Quantitative proteomics identify novel miR-155 target proteins. |
|
| QuickLIMS: facilitating the data management for DNA-microarray fabrication |
|
| Recollections of a scientific journey published in human genetics: from chromosome territories to interphase cytogenetics and comparative genome hybridization |
|
| Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). |
|
| Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas |
|
| Reply to J.C. Lindsey et al |
|
| The role of epigenetics in carcinogenesis |
|
| Screen of Compounds to Target Tumor Cells with Chromothripsis |
|
| Signatures of mutational processes in human cancer |
|
| Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort |
|
| Struktur und Expression genomischer Information für die schwere Kette eines menschlichen Myosins |
|
| Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling |
|
| Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma |
|
| Toward understanding and exploiting tumor heterogeneity |
|
| TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. |
|
| Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes |
|
| Tumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinoma |
|
| Utilizing gene expression profiling, phosphoproteomics and loss-of-function screens to enhance the therapeutic efficacy of dasatinib in glioblastoma |
|
| VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. |
|
| Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants |
|
